| Literature DB >> 28793539 |
Yung-Sheng Lin1, Kuo-Sheng Hung2,3, Ben-Yi Liau4, Chih-Hui Yang5, Aiga Yang6, Keng-Shiang Huang7.
Abstract
The purpose of this study is to assess the beneficial effects of a far-infrared-emitting collar (FIRC) on the management of neck disorders. A neck disorder is generalized as neck muscle pain and its relative mental disorders because the etiologies of the neck's multidimensional syndrome are either muscle impairment or psychiatric distress. This is the first study to determine the efficacy of a FIRC by evaluating objective physical evidence and psychometric self-reports using a parallel-arm randomized sham-controlled and single-blinded design. In this trial, 60 participants with neck disorders were observed at baseline and post-intervention. Compared to the placebo group after a 30-min intervention, the FIRC demonstrated a statistically significant biological effect in elevating skin temperature and promoting blood circulation with p-values 0.003 and 0.020, respectively. In addition, FIRC application significantly reduced neck muscle tension, relieved pain, ameliorated fatigue, improved depression, and decreased anxiety. The FIRC could therefore be a potential treatment for neck disorders.Entities:
Keywords: collar; far-infrared ray; neck; pain
Year: 2015 PMID: 28793539 PMCID: PMC5512659 DOI: 10.3390/ma8095279
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Comparison of measured results in the control group and the intervention group.
| Group | Placebo Group | FIR group | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Measurement | Pre | Post | Difference (Δ | Pre | Post | Difference (Δ | ||||
| Muscle hardness (N) | 30.43 ± 5.5 | 29.7 ± 4.6 | −0.7 ± 3.7 | 0.190 | 29.8 ± 4.5 | 28.9 ± 4.3 | −1.2 ± 2.8 | 0.026 * | 0.412 | |
| Skin temperature (°C) | 34.0 ± 0.6 | 35.1 ± 0.9 | 1.1 ± 0.9 | 0.001 * | 34.0 ± 0.7 | 35.9 ± 0.6 | 1.8 ± 0.9 | 0.001 * | 0.003 * | |
| Blood flow (PU) | 93.5 ± 23.8 | 174.4 ± 65.7 | 80.9 ± 63.0 | 0.001 * | 96.2 ± 21.3 | 228.9 ± 95.8 | 132.6 ± 96.8 | 0.001 * | 0.020 * | |
| Visual analogue scale | Pain | 3.6 ± 2.3 | 2.1 ± 1.8 | −1.5 ± 1.3 | 0.001 * | 3.8 ± 2.2 | 2.0 ± 1.9 | −1.7 ± 1.5 | 0.001 * | 0.433 |
| Anxiety | 2.8 ± 2.3 | 1.7 ± 2.1 | −1.1 ± 1.9 | 0.004 * | 3.5 ± 2.3 | 2.0 ± 1.8 | −1.8 ± 1.7 | 0.001 * | 0.077 | |
| Depression | 2.2 ± 2.2 | 1.3 ± 1.8 | −0.9 ± 1.4 | 0.002 * | 3.2 ± 2.3 | 1.7 ± 1.7 | −1.4 ± 1.6 | 0.001 * | 0.122 | |
| Fatigue | 4.6 ± 2.5 | 2.5 ± 2.1 | −2.1 ± 2.2 | 0.001 * | 5.2 ± 2.6 | 2.9 ± 2.2 | −2.4 ± 2.1 | 0.001 * | 0.615 | |
Placebo group: 12 males & 18 females, age: 19.7 ± 1.7 years; FIRC group: 13 males & 17 females, age: 19.6 ±2.3 years. A value of p < 0.05 was considered significant difference and labelled *.
Figure 1Changes in neck muscle hardness of placebo and FIRC groups before and after intervention. Asterisk indicates a significant difference.
Figure 2Changes in neck skin temperature of placebo and FIRC groups before and after intervention. Asterisk indicates a significant difference.
Figure 3Changes in blood flow of placebo and FIRC groups before and after intervention. Asterisk indicates a significant difference.
Figure 4Changes in VAS-Pain, VAS-Anxiety, VAS-Depression, and VAS-Fatigue of placebo and FIRC groups before and after intervention. Asterisk indicates a significant difference.
Figure 5The spectrum of FIR ceramics at 50 °C. The total intensity of the wavelengths between 4 µm and 16 µm is 12.37 mW/cm2.